Cargando…

CRMP5 Antibodies—Diagnostic Challenges

CRMP5-associated paraneoplastic neurological syndromes (PNS) are rare, and only few studies describe larger cohorts of patients with CRMP5 antibodies. We have included 24 patients with CRMP5 antibodies and compared clinical findings with diagnostic findings from two different line assays (Ravo and E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Totland, Cecilie, Haugen, Mette, Vedeler, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492982/ https://www.ncbi.nlm.nih.gov/pubmed/34630302 http://dx.doi.org/10.3389/fneur.2021.729075

Ejemplares similares

Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker
por: Herdlevær, Ida, et al.
Publicado: (2021)

Expression of the onconeural protein CDR1 in cerebellum and ovarian cancer
por: Totland, Cecilie, et al.
Publicado: (2018)

Case report: Seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1
por: Nes, Magne Solberg, et al.
Publicado: (2023)

CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration
por: Eichler, Tilo W., et al.
Publicado: (2013)

Case report: Pain in anti-DPPX encephalitis
por: Bjerknes, Tale L., et al.
Publicado: (2022)

CDR2 antigen and Yo antibodies
por: Totland, Cecilie, et al.
Publicado: (2010)

A Longitudinal, Observational Analysis of Neuronal Injury Biomarkers in a Case Report of a Patient With Paraneoplastic Anti-CRMP5 Antibody-Associated Transverse Myelitis
por: Mizenko, Christopher, et al.
Publicado: (2021)

Paraneoplastic Limbic Encephalitis Associated with Anti-CV2/CRMP5 Antibodies Secondary to Thymoma in an Adolescent
por: Ibrahim Ismail, Ismail, et al.
Publicado: (2020)

Anti-CV2/Collapsin Response Mediator Protein 5 (CRMP5) Paraneoplastic Encephalitis Induced by Small Cell Lung Cancer
por: Helgason, Veigar Þór, et al.
Publicado: (2023)

Phosphorylated CRMP1, axon guidance protein, is a component of spheroids and is involved in axonal pathology in amyotrophic lateral sclerosis
por: Kawamoto, Yuko, et al.
Publicado: (2022)

Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis
por: Greenlee, John E., et al.
Publicado: (2022)

Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis
por: Schubert, Manja, et al.
Publicado: (2014)

Encephalomyeloneuropathy with CRMP-5 antibodies in a patient with a primary mediastinal serinoma
por: Hampton, Cliff W., et al.
Publicado: (2015)

Encephalomyeloneuropathy with CRMP-5 antibodies in a patient with a primary mediastinal serinoma
Publicado: (2015)

CRMP-5-IgG Antibody: role in the bilateral uveitis with swollen disc
por: Hernández-Bel, Laura, et al.
Publicado: (2020)

An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes
por: Wang, Sai, et al.
Publicado: (2023)

CRMP-5 interacts with actin to regulate neurite outgrowth
por: GONG, XIAOBING, et al.
Publicado: (2016)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

CRMP2 and CRMP4 Are Differentially Required for Axon Guidance and Growth in Zebrafish Retinal Neurons
por: Liu, Zhi-Zhi, et al.
Publicado: (2018)

CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor
por: Fukushima, Hirofumi, et al.
Publicado: (2021)

Limbic encephalitis associated with AMPA receptor and CRMP5 antibodies: A case report and literature review
por: Jia, Yujuan, et al.
Publicado: (2020)

CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer
por: Nakajima, Masanori, et al.
Publicado: (2018)

Progressive striatal necrosis associated with anti-NMDA receptor antibodies
por: Tzoulis, Charalampos, et al.
Publicado: (2013)

Landau-Kleffner Syndrome: A Diagnostic Challenge
por: Ahmed, Mushtaq, et al.
Publicado: (2020)

CRMP4 and CRMP2 Interact to Coordinate Cytoskeleton Dynamics, Regulating Growth Cone Development and Axon Elongation
por: Tan, Minghui, et al.
Publicado: (2015)

Human CRMP4 mutation and disrupted Crmp4 expression in mice are associated with ASD characteristics and sexual dimorphism
por: Tsutiya, Atsuhiro, et al.
Publicado: (2017)

Editorial: Autoimmunity and the Brain: Paraneoplastic Neurological Injury and Beyond
por: Greenlee, John E., et al.
Publicado: (2022)

Diagnostic Challenge and Neuromuscular Junction Contribution to ALS Pathogenesis
por: Campanari, Maria-Letizia, et al.
Publicado: (2019)

Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature
por: Juárez-Vignon Whaley, Juan José, et al.
Publicado: (2021)

Small cell carcinoma presenting as ocular paraneoplastic syndrome due to CRMP-5
por: Castle, George, et al.
Publicado: (2020)

Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine
por: Robblee, Jennifer
Publicado: (2023)

Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management
por: Sechi, Elia, et al.
Publicado: (2021)

Artery of Percheron Infarct: An Acute Diagnostic Challenge with a Spectrum of Clinical Presentations
por: Khanni, Javed L, et al.
Publicado: (2018)

Parkinson’s Disease: Diagnostic Challenges Amidst Transdiagnostic and Overlapping Mental Health Symptoms
por: Madabushi, Jayakrishna S, et al.
Publicado: (2023)

Juvenile Huntington’s Disease: A Case Report and a Review of Diagnostic Challenges
por: Yu, Su-Yuan, et al.
Publicado: (2023)

Editorial: Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management
por: Zhang, Yin-Xi, et al.
Publicado: (2022)

Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain
por: Moutal, Aubin, et al.
Publicado: (2018)

Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine
por: Ha, Jongmok, et al.
Publicado: (2019)

AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
por: Prain, Kerri, et al.
Publicado: (2019)

Severe parkinsonism associated with anti-CRMP5 antibody-positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia
por: Tada, Satoru, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8av1l6k252rvj9bpe0polbaqa0